Stock BWVI BLUE WATER VENTURES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Blue Water Ventures International, Inc.

Equities

BWVI

US09609E1055

Market Closed - OTC Markets
Other stock markets
 03:02:26 2024-07-05 pm EDT 		5-day change 1st Jan Change
0.0015 USD 0.00% Intraday chart for Blue Water Ventures International, Inc. +15.38% -97.58%
Jun. 20 Blue Water Ventures International, Inc. announced that it expects to receive $10 million in funding CI
2023 Psycheceutical Bioscience, Inc. Announces Chief Executive Officer Changes CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Veru Sells ENTADFI Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones
AQ
Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review
PR
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab
GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD
GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD
AQ
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD
GL
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD
AQ
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
GL
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
AQ
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
GL
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
AQ
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
GL
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
AQ
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
GL
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
AQ
Mannatech is Reinventing Hydration Introduces Exclusive Blue Water
AQ
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
GL
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
AQ
Kevin Harrington, Original Shark from Shark Tank and Futurist Zappy Zapolin to Open Wonderland 2022
NE
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BWVI Stock
  4. News Blue Water Ventures International, Inc.
  5. Press Releases